Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-31
1991-09-10
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548255, 5482644, 548375, 548251, 546119, C07D24912, C07D24916, A61K 3141
Patent
active
050474162
ABSTRACT:
Azole compounds including azoles and azolium salts, and their use as transglutaminase inhibitors are disclosed.
REFERENCES:
patent: 4218476 (1980-08-01), Joensson et al.
patent: 4265898 (1981-05-01), Horstmann et al.
Kister et al., Can. J. Chem. 57,813 (1979).
Kister et al., Can. J. Chem. 57,822 (1979).
Baldwin John J.
Claremon David A.
King Stella W.
Remy David C.
Lee Mary C.
Merck & Co. , Inc.
Pfeiffer Hesna J.
Robertson Alice O.
Whittenbaugh Robert C.
LandOfFree
Triazole compounds and their use as transglutaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole compounds and their use as transglutaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds and their use as transglutaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-540272